Polatuzumab Vedotin, Zanubrutinib and Rituximab Achieved Rapid and Deep Response in Previously Untreated Frail and Elderly Diffuse Large B-Cell Lymphoma Patients

被引：0
|
作者：
Ren, Yuhong [1 ]
Zhuang, Jingli [2 ]
Yuan, Ling [2 ]
Ji, Lili [1 ]
Ke, Yang [1 ]
Liu, Peng [3 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Hematol, Shanghai, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Hematol, Shanghai, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186170
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The ZR2-Minichop Study:Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
    Sun, Jianai
    Xu, Yi
    Shi, Yuanfei
    Wang, Jinghan
    Li, Xueying
    Zheng, Xiaolong
    Yu, Wen-Juan
    Tong, Hongyan
    Jin, Jie
    Xie, Wanzhuo
    BLOOD, 2023, 142
  • [22] Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non-Asian patients with previously untreated diffuse large B-cell lymphoma in POLARIX
    Liao, Michael Z.
    Deng, Rong
    Gibiansky, Leonid
    Lu, Tong
    Agarwal, Priya
    Dere, Randall
    Lee, Calvin
    Hirata, Jamie
    Herbaux, Charles
    Salles, Gilles
    Li, Chunze
    Miles, Dale
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (12): : 2744 - 2755
  • [23] The ZR2-Minichop Study:Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
    Sun, Jianai
    Xu, Yi
    Yang, Min
    Wang, Huafeng
    Yu, Wenjuan
    You, Liangshun
    Meng, Haitao
    Yang, Chunmei
    Zhou, Xinping
    Li, Li
    Zhou, De
    Ye, Xiujing
    Zhu, Hong-hu
    Tong, Hongyan
    Jin, Jie
    Xie, Wanzhuo
    BLOOD, 2022, 140 : 3756 - 3756
  • [24] Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma
    Hajime Yasuda
    Naoko Kaga
    Hikari Taka
    Tomonori Ochiai
    Tomohito Yamana
    Yoshiki Miura
    Midori Ishii
    Makoto Sasaki
    Jun Ando
    Miki Ando
    Cancer Chemotherapy and Pharmacology, 2024, 93 (3) : 265 - 268
  • [25] Polatuzumab Vedotin: Honing in on Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Shingleton, Jennifer R.
    Dave, Sandeep S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 166 - +
  • [26] Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma
    Yasuda, Hajime
    Kaga, Naoko
    Taka, Hikari
    Ochiai, Tomonori
    Yamana, Tomohito
    Miura, Yoshiki
    Ishii, Midori
    Sasaki, Makoto
    Ando, Jun
    Ando, Miki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (03) : 265 - 268
  • [27] Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma
    Corcoran, Sean R.
    Phelan, James D.
    Choi, Jaewoo
    Shevchenko, Galina
    Fenner, Rachel E.
    Yu, Xin
    Scheich, Sebastian
    Hsiao, Tony
    Morris, Vivian M.
    Papachristou, Evangelia K.
    Kishore, Kamal
    D'Santos, Clive S.
    Ji, Yanlong
    Pittaluga, Stefania
    Wright, George W.
    Urlaub, Henning
    Pan, Kuan-Ting
    Oellerich, Thomas
    Muppidi, Jagan
    Hodson, Daniel J.
    Staudt, Louis M.
    CANCER DISCOVERY, 2024, 14 (09) : 1653 - 1674
  • [28] Spotlight on polatuzumab vedotin: new standards for diffuse large B-cell lymphoma?
    Ghione, Paola
    Salles, Gilles
    HAEMATOLOGICA, 2024, 109 (09) : 2802 - 2809
  • [29] Therapeutic potential of polatuzumab vedotin for the treatment of diffuse large B-cell lymphoma
    Qi, Hui
    Wang, Fuyang
    Han, Bingrui
    Wang, Xiaomin
    Qiang, Xiangnan
    Zhang, Zhixiang
    Gu, Qiangyang
    CANCER RESEARCH, 2023, 83 (07)
  • [30] Polatuzumab-R-CHP in Previously Untreated Diffuse Large B-Cell Lymphoma: A Retrospective Study
    Bobes, Alejandro
    Llorente, Laura
    Pradillo, Virginia
    Alonso, Aranzazu
    Fernandez, Ruben
    Garcia-Noblejas, Ana
    Lopez de la Osa, M. Jose
    Casanova, Maria
    Lorente, Soraya
    Iglesias, Rebeca
    Estevez, Monica
    De Ona, Raquel
    De La Fuente, Adolfo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S479 - S479
12345